4//SEC Filing
Johnson David Michael 4
Accession 0001725160-23-000201
CIK 0001725160other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:24 PM ET
Size
5.1 KB
Accession
0001725160-23-000201
Insider Transaction Report
Form 4
Johnson David Michael
Director
Transactions
- Purchase
Common Stock
2023-11-10$9.88/sh+17,000$167,943→ 144,389 total
Footnotes (1)
- [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $9.70 to $9.93. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001808098
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 5:24 PM ET
- Size
- 5.1 KB